Bayer AG

Bayer AG

BAYER · BUD · Healthcare / Drug Manufacturers - General

19,485.00HUF+1060.00 (+5.75%)

Price History

Full chart

Market Stats

Previous Close18,425.00
Open18,500.00
Day Range18,500.00 – 19,600.00
52-Week Range10,100.00 – 18,890.00
Volume615
Market Cap18.10T
P/E (TTM)0.00
Forward P/E10.74
EPS-673.45
Dividend Yield0.22%
Beta0.81
50-Day Avg17,289.70
200-Day Avg16,048.01

About

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. It has a commercial agreement with Neste to Jointly scale newgold winter canola for biofuels production. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. William N. Anderson
  • Employees87.83K
  • HeadquartersKaiser-Wilhelm-Allee 1, Leverkusen, Germany, 51368, Hungary
  • Websitehttps://www.bayer.com

Leadership

  • Mr. William N. AndersonChairman of the Management Board & CEO · b. 1966
  • Mr. Stefan OelrichPresident of the Pharmaceuticals Division & Member of the Board of Management · b. 1968
  • Ms. Heike PrinzChief Talent Officer, Labor Director & Member of Management Board · b. 1964
  • Dr. Judith HartmannCFO & Member of Management Board · b. 1969
  • Mr. Rodrigo SantosMember of Management Board, Head of the Crop Science Division & President of Crop Science Division · b. 1973
  • Mr. Julio TrianaMember of Management Board & President of Consumer Health Division · b. 1965
  • Mr. Alex BuschermohleChief Information Officer, Head-Digital Transformation & IT-Crop Science Division
  • Ms. Jana Marlen AckermannHead of the Investor Relations · b. 1984
  • Mr. Bill DoderoGeneral Counsel and Senior VP of Law Patents & Compliance
  • Mr. Michael PreussHead of Communications, Government Relations and Corporate Brand

Financials

Income Statement

Currency: EUR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue43.55B41.40B44.08B50.74B47.64B46.61B45.58B
Growth (%)--4.93%+6.48%+15.10%-6.11%-2.16%-2.21%
Cost of Revenue17.47B19.14B16.82B19.87B19.75B21.27B18.80B
Gross Profit26.08B22.26B27.27B30.87B27.89B25.34B26.78B
Gross Margin59.89%53.77%61.85%60.84%58.54%54.36%58.76%
Operating Expense21.55B22.98B20.36B23.54B19.85B22.01B20.64B
Operating Income4.53B-714.00M6.91B7.33B8.04B3.33B6.14B
Operating Margin10.41%-1.72%15.67%14.45%16.87%7.14%13.47%
EBITDA10.09B-2.40B6.45B13.03B10.45B8.81B1.92B
EBITDA Margin23.18%-5.79%14.63%25.68%21.93%18.90%4.22%
Net Income4.09B-10.49B1.00B4.15B-2.94B-2.55B-3.62B
Net Income Margin9.39%-25.35%2.27%8.18%-6.17%-5.48%-7.94%
R&D5.34B7.13B5.41B6.57B5.37B6.21B5.77B
R&D as % of Total Revenue12.27%17.21%12.28%12.95%11.27%13.32%12.66%
Interest Expense1.85B1.60B1.35B1.86B2.05B2.36B2.27B
Interest Expense % of Total Revenue4.24%3.86%3.06%3.66%4.30%5.06%4.97%

Balance Sheet

Currency: EUR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets126.26B117.05B120.24B124.88B116.26B110.85B104.54B
Total Liabilities78.74B86.35B87.07B85.95B83.18B78.81B78.48B
Total Equity47.34B30.52B33.02B38.77B32.93B31.91B25.95B
Cash3.19B4.19B4.56B5.17B5.91B6.19B6.67B
Net Debt34.45B36.23B33.80B34.91B35.73B33.26B28.50B

Cash Flow

Currency: EUR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow8.21B4.90B5.09B7.09B5.12B7.37B5.93B
Investing Cash Flow-671.00M-4.07B855.00M-2.38B---
Financing Cash Flow-8.39B423.00M-5.64B-4.22B---
Capital Expenditure2.65B2.42B2.61B2.95B2.75B2.78B2.49B
Free Cash Flow5.56B2.48B2.48B4.14B2.37B4.59B3.44B
Dividends Paid2.61B2.75B1.99B1.99B2.38B131.00M127.00M
FCF to OCF67.71%50.68%48.69%58.42%46.24%62.30%58.06%
Dividend Paid to FCF46.99%110.70%80.43%47.90%100.55%2.85%3.69%

Earnings

Report DateMar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 5, 2024May 14, 2024Aug 6, 2024Nov 12, 2024Mar 5, 2025May 13, 2025Aug 6, 2025Nov 12, 2025Mar 4, 2026May 12, 2026Aug 4, 2026Nov 3, 2026
EPS Estimate-----------------------------------------------------0.790.320.492.250.750.30
EPS Actual370.47172.82177.86126.14409.09296.10259.81161.04521.35346.95306.9682.29478.33419.37371.01228.10560.98514.79439.44162.45727.13428.041341.7052.02685.42276.72954.45-1365.53402.53132.90346.12477.83514.45-3419.77-987.16113.03768.01-843.4730.61430.681221.16-116.92224.15255.50860.00-715.93-1783.10520.03790.38-13.54-1677.83-139.01535.45-81.86-387.91-1477.701080.2280.50-
Surprise------------------------------------------------------10462.08%-121321.53%-301670.80%47909.64%10633.95%-
Timing-----------------------------------------------After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap18.10T
Enterprise Value28.67T
Trailing P/E0.00
Forward P/E10.74
PEG Ratio4.68
Price / Sales398.92
Price / Book1.66
EPS-673.45
Book Value30.11
Revenue (TTM)45.38B
Gross Profit (TTM)27.43B
EBITDA10.13B
Profit Margin-3.83%
Operating Margin9.19%
Return on Equity-5.69%
Return on Assets3.18%
Shares Outstanding982.42M
Shares Float982.42M
Beta0.81
Dividend Yield0.22%
Dividend Rate40.04
Payout Ratio162.16%

Dividends

20251×
44.49Apr 28, 2025
20241×
43.03Apr 29, 2024
20231×
897.34May 2, 2023
20221×
761.91May 2, 2022
20211×
723.81Apr 28, 2021
20201×
994.99Apr 29, 2020
20191×
906.04Apr 29, 2019
20181×
877.84May 28, 2018
20171×
829.64May 1, 2017
20161×
765.74May 2, 2016
20151×
685.11May 28, 2015
20141×
635.11Apr 30, 2014
20131×
558.69Apr 29, 2013
20121×
464.64Apr 30, 2012

Stock Splits

  • Jun 6, 2018503:495